Schott has set up a Ready to Use (RTU) centre of excellence at its Lebanon, PA production facility in the USA.
The facility brings together experts and pharma partners at the heart of manufacturing. The manufacturing plant will become a hub where experts can develop solutions to exploit the full potential of sterile packaging concepts.
The plant’s manufacturing capacity also ensures the security of supply of RTU vials and other pharma packaging.
Experts report that speciality drugs are driving medical growth in developing countries and the self-administered drug market is expected to double in the next five years.
Particle-related drug recalls have also increased more than 300% since 2012. As a result, the pharmaceutical industry must guarantee the safety of packaging. Pharmaceutical manufacturers are relying more on RTU packaging as it promotes particle-free drug filling, and allows for filling different container formats on the same filling line, making even the processing of smaller batch sizes cost-effective.
Christopher Cassidy, Vice President Sales and Marketing of Schott’s Pharmaceutical Systems in the USA, said: “Schott’s centre of excellence in Lebanon is the manifestation of the relationship we have with our partners, and our collaborative efforts create safe, reliable and easy-to-use packaging products.”
